(Q59822429)

12 December 2020

Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

1 reference

12 December 2020

Neutral endopeptidase protein expression and prognosis in localized prostate cancer

1 reference

12 December 2020

Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

1 reference

12 December 2020

Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival

1 reference

12 December 2020

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

1 reference

12 December 2020

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers

1 reference

12 December 2020

p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.

1 reference

12 December 2020

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma

1 reference

12 December 2020

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

1 reference

12 December 2020

Reporting bias in diagnostic and prognostic studies: time for action.

1 reference

12 December 2020

Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates

1 reference

12 December 2020

A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer

1 reference

12 December 2020

Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis

1 reference

12 December 2020

Use of multiple imputation in the epidemiologic literature

1 reference

12 December 2020

New prognostic markers for outcome of acute pancreatitis: overview of reporting in 184 studies

1 reference

12 December 2020

Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib

1 reference

12 December 2020

Recommendations for collection and handling of specimens from group breast cancer clinical trials

1 reference

12 December 2020

Evaluation of sampling strategies for modeling survival of uveal malignant melanoma

1 reference

12 December 2020

Identification of clinically useful cancer prognostic factors: what are we missing?

1 reference

12 December 2020

Weighted analyses for cohort sampling designs

1 reference

12 December 2020

Quantification of the completeness of follow-up.

1 reference

12 December 2020

Sample size considerations for the evaluation of prognostic factors in survival analysis

1 reference

12 December 2020

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

1 reference

12 December 2020

Biomarker studies: a call for a comprehensive biomarker study registry

1 reference

12 December 2020

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

1 reference

12 December 2020

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

1 reference

12 December 2020

Is treatment with interferon-alpha effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions

1 reference

12 December 2020

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

1 reference

12 December 2020

Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

1 reference

12 December 2020

Survival analysis part IV: further concepts and methods in survival analysis

1 reference

12 December 2020

Biospecimen Reporting for Improved Study Quality

1 reference

12 December 2020

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects

1 reference

12 December 2020

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

12 December 2020

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

12 December 2020

REporting recommendations for tumour MARKer prognostic studies (REMARK)

1 reference

12 December 2020

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer

1 reference

12 December 2020

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

12 December 2020

Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial

1 reference

12 December 2020

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis

1 reference

12 December 2020

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

1 reference

12 December 2020

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

12 December 2020

The impact of time-dependent bias in proportional hazards modelling

1 reference

12 December 2020

What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models

1 reference

12 December 2020

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

1 reference

12 December 2020

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I

1 reference

12 December 2020

Prognostic criteria for squamous cell cancer of the skin

1 reference

12 December 2020

Imputing missing covariate values for the Cox model

1 reference

12 December 2020

Calcified carotid artery atheroma and stroke: a systematic review

1 reference

12 December 2020

Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer

1 reference

12 December 2020

Loss of antigenicity in stored sections of breast cancer tissue microarrays

1 reference

12 December 2020

Glucose as a prognostic factor in ovarian carcinoma

1 reference

12 December 2020

Assessment of claims of improved prediction beyond the Framingham risk score

1 reference

12 December 2020

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

1 reference

12 December 2020

Cutpoints in clinical chemistry: time for fundamental reassessment

1 reference

12 December 2020

Tests for interaction in epidemiologic studies: A review and a study of power

1 reference

12 December 2020

A note on quantifying follow-up in studies of failure time

1 reference

12 December 2020

The risk of determining risk with multivariable models

1 reference

12 December 2020

Prospective or retrospective: what's in a name?

1 reference

12 December 2020

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.

1 reference

12 December 2020

Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network

1 reference

12 December 2020

The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts

1 reference

12 December 2020

Selective reporting biases in cancer prognostic factor studies

1 reference

12 December 2020

Almost all articles on cancer prognostic markers report statistically significant results

1 reference

12 December 2020

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

1 reference

12 December 2020

Subgroup analysis and other (mis)uses of baseline data in clinical trials

1 reference

12 December 2020

Survival analysis part I: basic concepts and first analyses

1 reference

12 December 2020

Multiple imputation: current perspectives

1 reference

12 December 2020

Survival probabilities (the Kaplan-Meier method).

1 reference

12 December 2020

Use of archived specimens in evaluation of prognostic and predictive biomarkers

1 reference

12 December 2020

Predicting the future: a critical appraisal of cancer prognosis studies

1 reference

12 December 2020

Cellular DNA content and survival in advanced ovarian carcinoma.

1 reference

12 December 2020

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines

1 reference

12 December 2020

Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example.

1 reference

12 December 2020

Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses

1 reference

12 December 2020

Interaction revisited: the difference between two estimates

1 reference

12 December 2020

Prognostic factor studies in oncology: osteosarcoma as a clinical example.

1 reference

12 December 2020

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

12 December 2020

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

1 reference

12 December 2020

Regression models for prognostic prediction: advantages, problems, and suggested solutions.

1 reference

12 December 2020

Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis

1 reference

12 December 2020

Value of flow diagrams in reports of randomized controlled trials.

1 reference

12 December 2020

Time-dependent relevance of steroid receptors in breast cancer

1 reference

12 December 2020

A systematic review of trends in the methodological quality of randomized controlled trials in various research fields

1 reference

12 December 2020

MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.

1 reference

12 December 2020

Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer

1 reference

12 December 2020

Diagnostic and prognostic impact of osteopontin expression in endometrial cancer

1 reference

12 December 2020

Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer

1 reference

12 December 2020

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

1 reference

12 December 2020

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

12 December 2020

Influence of model-building strategies on the results of a case-control study.

1 reference

12 December 2020

Joint estimation of time-dependent and non-linear effects of continuous covariates on survival.

1 reference

12 December 2020

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data

1 reference

12 December 2020

Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients

1 reference

12 December 2020

A systematic review of molecular and biological tumor markers in neuroblastoma

1 reference

12 December 2020

The search for truth must go beyond statistics

1 reference

12 December 2020

Outcome selection bias in meta-analysis

1 reference

12 December 2020

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

1 reference

12 December 2020

End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?

1 reference

12 December 2020

Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines

1 reference

12 December 2020

Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease

1 reference

12 December 2020

Measuring Follow-Up Completeness

1 reference

12 December 2020

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial

1 reference

12 December 2020

A new proposal for multivariable modelling of time-varying effects in survival data based on fractional polynomial time-transformation

1 reference

12 December 2020

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

12 December 2020

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma

1 reference

12 December 2020

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

1 reference

12 December 2020

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer

1 reference

12 December 2020

Statistical aspects of prognostic factor studies in oncology

1 reference

12 December 2020

Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates

1 reference

12 December 2020

Survival analysis part II: multivariate data analysis--an introduction to concepts and methods

1 reference

12 December 2020

Time-dependent covariates in the Cox proportional-hazards regression model

1 reference

12 December 2020

REporting recommendations for tumour MARKer prognostic studies (REMARK).

1 reference

12 December 2020

Prognosis and prognostic research: validating a prognostic model

1 reference

12 December 2020

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients

1 reference

12 December 2020

Validation of biomarker-based risk prediction models

1 reference

12 December 2020

A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions.

1 reference

12 December 2020

Selection of important variables and determination of functional form for continuous predictors in multivariable model building

1 reference

12 December 2020

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis

1 reference

12 December 2020

Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)

1 reference

12 December 2020

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

1 reference

12 December 2020

Increased shedding of HU177 correlates with worse prognosis in primary melanoma

1 reference

12 December 2020

Different detection rates of HER-2/NEU overexpression in ovarian carcinoma using two different commercially available detection kits

1 reference

12 December 2020

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy

1 reference

12 December 2020

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

1 reference

12 December 2020

Review: a gentle introduction to imputation of missing values

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies (remark).

1 reference

12 December 2020

Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.

1 reference

12 December 2020

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

12 December 2020

Evaluating a new marker's predictive contribution.

1 reference

12 December 2020

Independent predictors from stepwise logistic regression may be nothing more than publishable P values.

1 reference

12 December 2020

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

1 reference

12 December 2020

Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect

1 reference

12 December 2020

Review of survival analyses published in cancer journals

1 reference

12 December 2020

Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.

1 reference

12 December 2020

Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint.

1 reference

12 December 2020

A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials

1 reference

12 December 2020

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

1 reference

12 December 2020

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

12 December 2020

What do we mean by validating a prognostic model?

1 reference

12 December 2020

Blood markers for the prognosis of ischemic stroke: a systematic review

1 reference

12 December 2020

Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy

1 reference

12 December 2020

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

1 reference

12 December 2020

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

1 reference

12 December 2020

Competing risks and time-dependent covariates

1 reference

12 December 2020

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

12 December 2020

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

1 reference

12 December 2020

On power and sample size for studying features of the relative odds of disease

1 reference

12 December 2020

Multiple imputation of missing blood pressure covariates in survival analysis

1 reference

12 December 2020

Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis

1 reference

12 December 2020

Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies

1 reference

12 December 2020

Issues in the reporting of epidemiological studies: a survey of recent practice

1 reference

12 December 2020

Current perspectives on HER2 testing: a review of national testing guidelines

1 reference

12 December 2020

Bias as a threat to the validity of cancer molecular-marker research

1 reference

12 December 2020

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

1 reference

12 December 2020

Multivariate analysis of prognostic factors in patients with glioblastoma

1 reference

12 December 2020

Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians

1 reference

12 December 2020

Methodological challenges in the evaluation of prognostic factors in breast cancer

1 reference

12 December 2020

Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx

1 reference

12 December 2020

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

12 December 2020

Survival end point reporting in randomized cancer clinical trials: a review of major journals

1 reference

12 December 2020

Randomized clinical trials with biomarkers: design issues

1 reference

12 December 2020

Prognostic factors in non-small cell lung cancer: a decade of progress

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

12 December 2020

Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain

1 reference

12 December 2020

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

12 December 2020

Interactions between treatment and continuous covariates: a step toward individualizing therapy

1 reference

12 December 2020

The challenge of subgroup analyses--reporting without distorting

1 reference

12 December 2020

Time-dependent bias was common in survival analyses published in leading clinical journals.

1 reference

12 December 2020

Leave 'em alone - why continuous variables should be analyzed as such

1 reference

12 December 2020

Relaxing the rule of ten events per variable in logistic and Cox regression

1 reference

12 December 2020

Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.

1 reference

12 December 2020

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

12 December 2020

Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models

1 reference

12 December 2020

Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections

1 reference

12 December 2020

Why Most Discovered True Associations Are Inflated

1 reference

12 December 2020

Standard reference material for Her2 testing: report of a National Institute of Standards and Technology-sponsored Consensus Workshop

1 reference

12 December 2020